Zhongshan Ketogenic Diet Study 1
NCT07117903 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2025-08-12
Summary
This dietary intervention study was designed to investigate the impact of a ketogenic diet on platelet function and and thrombus formation. Based on our preclinical observations, the study also aimed to discover whether aspirin could effectively counteract the ketogenic diet-induced enhancement of platelet function and attenuate the associated prothrombotic state.
Conditions
- Platelet Function and Thrombus Formation
Interventions
- DIETARY_SUPPLEMENT
-
Normal diet + vehicle
Participants in the control group were instructed to maintain their usual diet for the duration of the study. While they were free to choose their food, they were required to provide a detailed dietary record. After diet intervention, whole blood will be drawn and incubated with vehicle drug.
- DIETARY_SUPPLEMENT
-
Normal diet + aspirin
Participants in the control group were instructed to maintain their usual diet for the duration of the study. While they were free to choose their food, they were required to provide a detailed dietary record. After diet intervention, whole blood will be drawn and incubated with aspirin.
- DIETARY_SUPPLEMENT
-
Ketogenic diet + vehicle
The calorie-restricted KD intervention consisted of a very-low-carbohydrate, high-fat diet (5% of calories from carbohydrates, 30% from protein, and 65% from fat, with an energy deficit of 600 kcal/day, 3 meals distributed over 24 h: breakfast, lunch, and dinner). This intervention was performed without schedule restrictions and supported by commercial replacement meals only for the first meal (100 kcal, 15 g of protein, 3 g of fat, of which 1 g was saturated fat, and 50 mg of docosahexaenoic acid, 2 g of carbohydrates, of which \< 1 g was simple sugars). After diet intervention, whole blood will be drawn and incubated with vehicle drug.
- DIETARY_SUPPLEMENT
-
Ketogenic diet + aspirin
The calorie-restricted KD intervention consisted of a very-low-carbohydrate, high-fat diet (5% of calories from carbohydrates, 30% from protein, and 65% from fat, with an energy deficit of 600 kcal/day, 3 meals distributed over 24 h: breakfast, lunch, and dinner). This intervention was performed without schedule restrictions and supported by commercial replacement meals only for the first meal (100 kcal, 15 g of protein, 3 g of fat, of which 1 g was saturated fat, and 50 mg of docosahexaenoic acid, 2 g of carbohydrates, of which \< 1 g was simple sugars). After diet intervention, whole blood will be drawn and incubated with aspirin.
Sponsors & Collaborators
-
Fudan University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-08-10
- Primary Completion
- 2025-08-18
- Completion
- 2025-08-20
Countries
- China
Study Locations
More Related Trials
-
KEtogenic Diet and Its Multiple EffectS on Obesity
NCT05898204 ·Status: COMPLETED ·Phase: NA
-
Dietary Ketosis: Fatty Acids Activate AMPK Energy Circuits Modulating Global Methylation
NCT03319173 ·Status: COMPLETED ·Phase: NA
-
Effects of Diet Interventions on Monocytes in Metabolic Syndrome
NCT03591588 ·Status: COMPLETED ·Phase: NA
-
Effects of a Ketogenic Diet on Acute Stroke
NCT01997749 ·Status: COMPLETED ·Phase: PHASE1
-
Ketogenic Diet - a Randomized, Controlled, Cross-over Study
NCT02417350 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial Imaging
NCT04275453 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea
NCT02069197 ·Status: UNKNOWN ·Phase: PHASE2
-
Dietary Interventions in Prediabetes
NCT01729078 ·Status: COMPLETED ·Phase: NA
-
Long Term Effect of Very-low-calories Ketogenic Diet on Weight Control and Cardiovascular Brisk Factors (KETOHEART)
NCT05781269 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of Ketone Ester Supplementation and Ketogenic Diet on Brain Plasticity in Overweight/Obese Adults
NCT06368297 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of Ketogenic-caloric Restricted Diet on Metabolic Endotoxemia in Prediabetic Obese Adults
NCT06911879 ·Status: COMPLETED ·Phase: NA
-
Network Meta-analysis of Intermittent Fasting and Cardiometabolic Risk
NCT05309057 ·Status: UNKNOWN
-
Effects of Dietary Manipulation on Metabolism in Healthy Adults
NCT00476125 ·Status: COMPLETED ·Phase: NA
-
Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity in Healthy Subjects
NCT05980858 ·Status: COMPLETED ·Phase: NA
-
Effects of Ketone Monoesters on Brain Function
NCT06395051 ·Status: COMPLETED ·Phase: NA
-
Ramadan Fasting Effects in Patients With Cardiovascular Risk Factors
NCT02720133 ·Status: COMPLETED
-
Raspberry Ketone Intake Upregulates Circulating FGF21 and Induces Energy Expenditure in Humans
NCT06681597 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications
NCT04353869 ·Status: COMPLETED
-
Effects of a Ketogenic Diet on Psychological Outcomes
NCT04086498 ·Status: COMPLETED ·Phase: NA
-
Metabolic Impact of Intermittent Fasting in Early Type 2 Diabetes
NCT05717127 ·Status: COMPLETED ·Phase: NA
-
Effects of Intermittent Fasting on Insulin Resistance, Cardiac Metabolism, and Cerebral Perfusion
NCT05181267 ·Status: COMPLETED ·Phase: NA
-
Effects of Olive Oil and MLCT on Glycolipid Homeostasis in Patients With Metabolic Syndrome
NCT05233917 ·Status: COMPLETED ·Phase: NA
-
Effects of Lipemia and Metformin on Endothelial Function
NCT01037660 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Study of Inflammation on Blood Glucose Levels in Obese People
NCT00258115 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Regulation of Muscle Glucose Metabolism
NCT01581736 ·Status: TERMINATED ·Phase: PHASE1